Drugs / recombinant growth hormone
recombinant growth hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00497562 | May 2004 → Nov 2005 | fibromyalgia, pituitary deficiency | Centro Medico Teknon | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant growth hormone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00497562 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Growth Hormone” NCT00497562 ↗ |
| Route | Subcutaneous | “0.0125 mg/kg/d of GH subcutaneously” PMID 18053120 ↗ Nov 2007 |